---
id: bioactivity
title: Bioactivity
description: Concept page defining bioactivity and its role in computational toxicology.
slug: /concepts/bioactivity
sidebar_label: Bioactivity
page_type: concept
entity_class: concept
status: draft
last_reviewed: 2026-08-25
---

# Overview

Bioactivity refers to the ability of a chemical substance to interact with biological systems, producing a measurable response. In computational toxicology, bioactivity data is essential for understanding the potential effects of chemicals on human health and the environment. This page defines bioactivity, explores its measurement methods, and discusses its significance in computational toxicology.

# Key Claims or Definitions

## Definition of Bioactivity

**Claim ID:** clm-bioactivity-001

**Statement:** Bioactivity is the capacity of a chemical to interact with biological targets, such as proteins, receptors, or DNA, leading to a measurable biological response.

**Subject:** Bioactivity
**Predicate:** is_defined_as
**Object:** Capacity of a chemical to interact with biological targets

**Qualifiers:**
- **Context:** Computational toxicology

**Citations:**
- cit-001

**Verification Status:** supported
**Confidence:** high

---

## Measurement of Bioactivity

**Claim ID:** clm-bioactivity-002

**Statement:** Bioactivity is typically measured using in vitro assays, such as high-throughput screening (HTS) assays, which evaluate the interaction of chemicals with specific biological targets.

**Subject:** Bioactivity
**Predicate:** is_measured_using
**Object:** In vitro assays

**Qualifiers:**
- **Assay Type:** High-throughput screening (HTS)

**Citations:**
- cit-002

**Verification Status:** supported
**Confidence:** high

---

## Role in Computational Toxicology

**Claim ID:** clm-bioactivity-003

**Statement:** Bioactivity data is used in computational toxicology to predict the potential toxicity of chemicals, identify mechanisms of action, and support regulatory decision-making.

**Subject:** Bioactivity data
**Predicate:** is_used_in
**Object:** Computational toxicology

**Qualifiers:**
- **Purpose:** Toxicity prediction, mechanism identification, regulatory support

**Citations:**
- cit-003

**Verification Status:** supported
**Confidence:** high

---

# Evidence or Details

## In Vitro Assays for Bioactivity Measurement

In vitro assays are widely used to measure bioactivity due to their ability to rapidly screen large numbers of chemicals. These assays often involve the use of cell lines or isolated proteins to evaluate the interaction of chemicals with specific biological targets. For example, high-throughput screening (HTS) assays, such as those used in the ToxCast and Tox21 programs, generate bioactivity data for thousands of chemicals across a range of endpoints.

## Computational Modeling and Bioactivity

Computational models, such as quantitative structure-activity relationship (QSAR) models, use bioactivity data to predict the potential effects of chemicals. These models rely on the relationship between chemical structure and biological activity to make predictions about the toxicity of new or untested chemicals. Machine learning techniques are increasingly being applied to bioactivity data to improve the accuracy and reliability of these predictions.

## Integration with Adverse Outcome Pathways (AOPs)

Bioactivity data is often integrated with adverse outcome pathways (AOPs) to understand the sequence of events leading to adverse health effects. AOPs provide a framework for linking molecular initiating events, such as bioactivity interactions, to observable outcomes, such as disease or toxicity. This integration supports the development of more comprehensive and mechanistic models of chemical toxicity.

# Related Pages

- [ToxCast](07-datasets/toxcast.md)
- [QSAR Models](08-models-and-methods/qsar-models.md)
- [Adverse Outcome Pathways](02-concepts/adverse-outcome-pathway.md)

# Open Questions or Review Notes

- How can bioactivity data be better integrated with in vivo toxicity data to improve predictive models?
- What are the limitations of current bioactivity assays, and how can they be addressed?
- How can machine learning techniques be further optimized to handle the complexity and variability of bioactivity data?

# References

```yaml
citation_id: cit-001
source_type: review
title: "Accurate prediction of activity cliff compounds based on bioactivity profiles depends on assay nearest neighbor relationships."
authors:
  - Ryuto Abe
  - Tomoyuki Miyao
  - Jürgen Bajorath
year: 2026
container: Journal of Cheminformatics
doi: 10.1186/s13321-026-01210-9
url: https://doi.org/10.1186/s13321-026-01210-9
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Defines bioactivity in the context of compound interactions and assay relationships.
```

```yaml
citation_id: cit-002
source_type: review
title: "From Agri-Food Byproducts to High-Value Bioactive Compounds: A Critical Review Linking Green Recovery and Chemical Profiling to Circular Valorization."
authors:
  - Hyo Jun Won
  - Ae-Jin Choi
year: 2026
container: Molecules
doi: 10.3390/molecules31122136
url: https://doi.org/10.3390/molecules31122136
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Discusses the measurement of bioactivity in the context of chemical profiling and extraction methods.
```

```yaml
citation_id: cit-003
source_type: review
title: "Democratizing Artificial Intelligence in Toxicology: Real-World Applications and Automated Computational Workflows."
authors:
  - Kamel Mansouri
  - José Teófilo Moreira-Filho
  - Ricardo S Tieghi
  - Nicole Kleinstreuer
year: 2026
container: Chemical Research in Toxicology
doi: 10.1021/acs.chemrestox.6c00093
url: https://doi.org/10.1021/acs.chemrestox.6c00093
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Highlights the role of bioactivity data in computational toxicology and AI-driven workflows.
```